Company identity 1 fact
Location
Silver Spring, MD
SEC filing record 1 fact
Fiscal year end
31 December
UNITED THERAPEUTICS Corp has filed 4,224 SEC EDGAR filings since 16 Apr 1999

SEC filing history

Showing 201-225 of 1,000 matching filings.

Per page
25
Current page
9
4

PRIMARY DOCUMENT

Filing date
16 Dec 2025
Reporting date
15 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
16 Dec 2025
Reporting date
15 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26301

144 filing

Filing date
16 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26301

144 filing

Filing date
15 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26301

144 filing

Filing date
15 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Dec 2025
Reporting date
11 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Dec 2025
Reporting date
11 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Dec 2025
Reporting date
11 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26301

144 filing

Filing date
12 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26301

144 filing

Filing date
11 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26301

144 filing

Filing date
11 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
10 Dec 2025
Reporting date
09 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
10 Dec 2025
Reporting date
08 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26301

144 filing

Filing date
10 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26301

144 filing

Filing date
09 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
09 Dec 2025
Reporting date
08 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
09 Dec 2025
Reporting date
08 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26301

144 filing

Filing date
09 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26301

144 filing

Filing date
08 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
08 Dec 2025
Reporting date
05 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
05 Dec 2025
Reporting date
03 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26301

144 filing

Filing date
05 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26301

144 filing

Filing date
04 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26301

144 filing

Filing date
03 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
02 Dec 2025
Reporting date
01 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .